Navigation Links
TANDEM DIABETES CARE BECOMES PRESENTING SPONSOR OF THE GREATEST AWARDS SHOW IN DIABETES
Date:8/8/2013

SAN DIEGO, Aug. 8, 2013 /PRNewswire-iReach/ -- Insulindependence (IN) announced today that Tandem Diabetes Care, manufacturer of the t:slim® Insulin Pump, has become the Presenting Sponsor of The Greatest Awards Show in Diabetes. The event will be hosted at the House of Blues in San Diego, August 17, 2013, as the red carpet highlight of IN's 2013 North American Conference on Diabetes and Exercise. This year's show will bring together some of the biggest names in diabetes to recognize the year's most notable achievements in diabetes and sport.

Masters of Ceremonies are diabetes patient blogger Kerri Morrone Sparling and Mt. Everest Climber and Ironman Triathlete Sebastien Sasseville.

Insulindependence and Tandem Diabetes Care will honor eight individuals, including this year's winner of the Paula and Lew Harper Collegiate Scholarship ($1,000) and Grand Prize Athletic Achievement Award ($5,000). The public is invited to vote on nominees via the Insulindependence website through August 15, 2013.

"It's a unique privilege to work with a local partner on an international scale," said Peter Nerothin, Founder and President of Insulindependence. "Tandem brings an electrifying energy that's a perfect match for our overarching goal of empowerment."

"The diabetes community never ceases to inspire us, and this program is a perfect example of the reasons why," said Kim Blickenstaff, president and CEO of Tandem Diabetes Care. "We are proud to be a supporter of Insulindependence and the active diabetes community, and we look forward to a great event."

Tickets for The Greatest Awards Show in Diabetes are for sale online for purchase by the public: http://www.insulindependence.org/in-conference/athletic-achievement-award/attend-the-show/

About Insulindependence |

Insulindependence (IN) (www.insulindependence.org) is a nonprofit member association dedicated to uniting, expanding, and supporting the active diabetes community. With support from over 4,000 individual members, 8,000 donors and a growing number of member organizations, we are a leading authority in exercise and recreation for people living with diabetes. Through excellence in member services, outreach, and education we are actively pursuing our vision to reduce the burden of diabetes in the United States through physical activity and peer support.

About Tandem Diabetes Care |

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a privately held company dedicated to advancing the management of diabetes through novel technologies. The Company offers a comprehensive, user-centric and integrated approach to product design, development, and customer care. Tandem Diabetes Care is based in San Diego, Calif.

Media Contact: Blair Ryan, Insulindependence, Inc., 888.912.3837 Ext. 108, Blair@insulindependence.org

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Insulindependence, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tandem Diabetes Care Acquires Select Patents and Patent Applications from Smiths Medical
2. Data Related to Chimerixs Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings
3. Data Demonstrating the Safety and Efficacy of Chimerixs Antiviral CMX001 Presented at BMT Tandem Meetings
4. Tandem Diabetes Care Names Lonnie Smith As Chairman Of The Board
5. Tandem Diabetes Care Announces FDA Clearance of t:connect Diabetes Management Application for Use with t:slim Insulin Pump
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
8. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
9. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
10. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
11. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... --  Divoti USA will engrave and process all ... the latest FDA requirements, which stipulates new criteria regarding medical device ... of Medical ID jewelry such as Medical ID Bracelets, can rest ... terms of the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
Breaking Medicine Technology:
(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
Breaking Medicine News(10 mins):